Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 07, 2018
Novartis announced an additional strategic alliance with Science 37 to initiate up to 10 new clinical trials over the next three years.
read more
Thursday, December 20, 2018
Novartis has announced an offer to acquire CellforCure from LFB.
read more
Novartis announced Shannon Thyme Klinger, Chief Legal Officer, has decided to resign from Novartis and return to the US to take an executive role at a biotechnology company.
read more
Novartis has announced Richard Francis will be stepping down as CEO of Sandoz, a Novartis division, and as a member of the Executive Committee of Novartis on March 31, 2019.
read more
Wednesday, October 19, 2022
Bend Bioscience and QHP Capital announced plans to invest in a new operation in Bend, Oregon, an emerging biotechnology R&D and manufacturing epicenter.
read more
Wednesday, December 23, 2020
NovAliX has announced an investment in its DEL platform as part of an eight-year technological cooperation agreement signed with a global pharmaceutical group.
read more
Tuesday, November 30, 2021
NovAliX, a Contract Research Organization (CRO) specializing in drug research and development, announced its partnership with Sanofi for the development of new DNA-Encoded Libraries (DELs). This multi-year agreement will see the partners join forces ...
read more
NovAliX, a drug discovery-focused Contract Research Organization (CRO), today announces the expansion of it's cryogenic electron microscopy (cryo-EM) technology capability.
read more
NovAliX, a drug discovery-focused Contract Research Organization (CRO), has announced the appointment of Dr. Jerome Guillemont as head of drug discovery.
read more
NovAliX, a specialized Contract Research Organization dedicated to enabling drug discovery, announced its long-term strategic partnership with the Max Planck Institute (MPI) for Multidisciplinary Sciences in Göttingen.
read more
Wednesday, August 07, 2024
NovAliX has formed a strategic partnership with Bruker under which Bruker has taken a minority ownership stake in NovAliX. The strategic investment underscores the increasingly vital role being played by CROs in global drug discovery and research.
read more
Wednesday, February 24, 2021
Within the scope of this partnership, HALIX will provide manufacturing of clinical supply of NovalGen’s therapies.
read more
Thursday, January 02, 2020
Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs has received FDA approval for their generic version of Febuxostat 40mg and 80mg tablets.
read more
Novadoz, the U.S based sales & marketing affiliate for MSN Labs, based in Hyderabad India, has received FDA approval for their generic version of Pregabalin capsules.
read more
Novadoz has received FDA approval for their generic versions of Oseltamivir Phosphate Capsules and Dofetilide Capsules.
read more